Skip to main content
. 2018 Jun 14;9(13):2408–2414. doi: 10.7150/jca.24236

Table 3.

Change in MVD of non-tumorous area at 1 week after sorafenib use

Change of blood flow in non-tumorous area MVD P value
Before sorafenib use One week after sorafenib use
Decrease (n = 6) 43.0 ± 1.0 23.0 ± 3.4 P < 0.05
No change (n = 6) 44.0 ± 5.2 44.3 ± 5.9 NS

MVD: microvascular density